Norton Rose Fulbright is the top firm for underwriter’s counsel work in the public finance and bond industry according to Refinitiv‘s US Municipals Review. The firm was ranked number one for… Read More
VICTORIA, BC – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA), a leader in full-service therapeutic antibody discovery and development, today announced financial results for second… Read More
Nine abstracts across Takeda’s hematology portfolio and pipeline demonstrate Takeda’s commitment to patient-centric, innovative care that aims to drive greater treatment outcomes Includes data exploring ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] in… Read More
Novo Nordisk today announced plans to invest more than 17 bn Danish kroner in construction of three new manufacturing facilities as well as expansion of one existing facility at its production… Read More
entrepreneurship@UBC is looking for the next generation of UBC researchers and scientists ready to translate innovation to impact for their Spring 2022 Lab2Launch cohort! For teams with a UBC connection,… Read More
